CME/CE
65-80 of 160
Robert J. Mentz, MD, FHFSA, FACC
Piotr Ponikowski, MD, PhD, FESC, FHFA
Daniel Gaudet, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Prof. Kausik Ray
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Kausik Ray, MBChB, MD, MPhil
Daniel Gaudet, MD, PhD
Pam R. Taub, MD, FACC, FASPC
MinuteCE®Setting the Bar: Guideline-Recommended Treatment in Hypertriglyceridemia
1.00 program creditBørge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Faiez Zannad, MD, PhD
John McMurray, OBE, BSc, MB ChB (Hons), MD, FRCP, FRSE, FMedSci, FESC, FACC, FAHA, FJCS, FHFA, FHFSA, FBSH
Daniel Gaudet, MD, PhD
Børge G. Nordestgaard, MD, DMSc
Kausik Ray, MBChB, MD, MPhil
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
- Broadcast Replay
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Riccardo Maria Inciardi, MD, PhD
Cristina Gavina, MD, PhD
Giuseppe Galati, MD
Thor Edvardsen, MD, PhD
Maurizio Pieroni, MD, PhD
Elena Arbelo, MD, PhD
- MinuteCE®
Role of echocardiography in risk stratification and treatment decision-making
0.52 program creditsMaurizio Pieroni, MD, PhD